These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 9278848)
41. [Perioperative adverse events related to antidepressive agents use]. Rozec B; Cinotti R; Blanloeil Y Ann Fr Anesth Reanim; 2011 Nov; 30(11):828-40. PubMed ID: 22019304 [TBL] [Abstract][Full Text] [Related]
42. Monoamine oxidase inhibitors and cardiac anesthesia revisited. Noorily SH; Hantler CB; Sako EY South Med J; 1997 Aug; 90(8):836-8. PubMed ID: 9258314 [TBL] [Abstract][Full Text] [Related]
43. Clinical pharmacokinetics and pharmacodynamics of selegiline. An update. Mahmood I Clin Pharmacokinet; 1997 Aug; 33(2):91-102. PubMed ID: 9260033 [TBL] [Abstract][Full Text] [Related]
44. Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information. Hisaka A; Ohno Y; Yamamoto T; Suzuki H Pharmacol Ther; 2010 Feb; 125(2):230-48. PubMed ID: 19951720 [TBL] [Abstract][Full Text] [Related]
45. Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions. Goulet JP; Pérusse R; Turcotte JY Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):692-7. PubMed ID: 1359489 [TBL] [Abstract][Full Text] [Related]
46. Inhibition and induction of cytochrome P450 and the clinical implications. Lin JH; Lu AY Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089 [TBL] [Abstract][Full Text] [Related]
48. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. Ponto LB; Perry PJ; Liskow BI; Seaba HH Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909 [TBL] [Abstract][Full Text] [Related]
49. Tranylcypromine in mind (Part I): Review of pharmacology. Ulrich S; Ricken R; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495 [TBL] [Abstract][Full Text] [Related]
50. Specific drug interactions in anaesthesia. Davie IT Anaesthesia; 1977; 32(10):1000-8. PubMed ID: 23013 [TBL] [Abstract][Full Text] [Related]
51. Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence. Prasopthum A; Pouyfung P; Sarapusit S; Srisook E; Rongnoparut P Drug Metab Pharmacokinet; 2015 Apr; 30(2):174-81. PubMed ID: 25857233 [TBL] [Abstract][Full Text] [Related]
53. Beware -- the use of MAO inhibitors is increasing again. Brown TC; Cass NM Anaesth Intensive Care; 1979 Feb; 7(1):65-8. PubMed ID: 434448 [TBL] [Abstract][Full Text] [Related]
57. Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants. Murray M; Field SL Biochem Pharmacol; 1992 May; 43(10):2065-71. PubMed ID: 1599495 [TBL] [Abstract][Full Text] [Related]
58. Drug interactions in anaesthesia. Vuyk J Minerva Anestesiol; 1999 May; 65(5):215-8. PubMed ID: 10389395 [TBL] [Abstract][Full Text] [Related]
59. Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine. Caporaso NE; Shaw GL Arch Intern Med; 1991 Oct; 151(10):1985-92. PubMed ID: 1681790 [TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic interactions between alcohol and other drugs. Fraser AG Clin Pharmacokinet; 1997 Aug; 33(2):79-90. PubMed ID: 9260032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]